Cited by 29Acne and Rosacea Treatments and EffectsDermatology and Skin DiseasesProstate Cancer Treatment and Research

Inhibition of 5α-Reductase Activity in SZ95 Sebocytes and HaCaT Keratinocytes In Vitro

Seiffert, K., Seltmann, H., Fritsch, M., Zouboulis, C.·2007·Hormone and Metabolic Research

Abstract

Inhibition of 5alpha-reductase type 1 has been considered to be a promising target for treatment of androgen-dependent skin disorders, however, currently published clinical results on acne treatment are rather disappointing. In this study, the influence of selective inhibitors of 5alpha-reductase on testosterone metabolism within SZ95 sebocytes and HaCaT keratinocytes IN VITRO was investigated. In both cell types, the isotype 1 inhibitor MK386 completely inhibited the conversion of testosterone to 5alpha-dihydrotestosterone in concentrations higher than 10 (-9) M. Inhibitors of the isotype 2 such as finasteride, dihydrofinasteride, and turosteride, were >100-fold less active, while, as expected, androgen receptor inhibitors did not affect the 5alpha-reductase activity. MK386, but not finasteride, reduced testosterone-stimulated proliferation and slightly reduced the testosterone-induced increase in the amount of SZ95 sebocyte proteins. The androgen receptor inhibitor cyproterone acetate exhibited no effect on testosterone-induced proliferation, but inhibited the 5alpha-dihydrotestosterone-induced sebocyte proliferation. Our experimental findings and the existing clinical results indicate that the inhibition of 5alpha-reductase activity alone may be insufficient to reduce overall sebocyte activity and improve acne lesions.

Integrity signals

Registry

Crossref · 10.1055/s-2007-961814

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Cited by

Sorted by citations

Authors
Seiffert, K., Seltmann, H., Fritsch, M., & Zouboulis, C.
Venue
Hormone and Metabolic Research
Published
2007-02
Volume
39
Issue
2
Pages
141-148
ISSN
  • 0018-5043 (ISSN-L)
  • 1439-4286
OpenAlex
W1975206613
Cited by
28
References
0
Citations by year
2024: 3 · 2022: 3 · 2020: 4 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 2
FWCI
2.55
Type
journal article
Language
en
Open access
closed
Locations
  • Hormone and Metabolic Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
Keywords
5α-reductase inhibition, 5α-reductase type 1, dihydrotestosterone, testosterone metabolism, sebocytes, keratinocytes, acne, finasteride, cyproterone acetate, androgen receptor
MeSH terms
Androgens, Azasteroids, Cells, Cultured, Humans, Sebaceous Glands, Testosterone, Protein Biosynthesis, Keratinocytes, Finasteride, Cholestenone 5 alpha-Reductase, Cell Proliferation, Androgen Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review